Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced the convening of its Annual General Meeting on June 26, 2025, in Shanghai. The announcement indicates that the number of shareholders who have confirmed their attendance does not exceed half of the total voting shares, which may impact the decision-making process at the meeting.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and services.
Average Trading Volume: 7,222,122
Technical Sentiment Signal: Buy
Current Market Cap: HK$65.28B
For an in-depth examination of 2607 stock, go to TipRanks’ Overview page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue